# Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient

> **NCT01187654** · PHASE2,PHASE3 · COMPLETED · sponsor: **Royan Institute** · enrollment: 80 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **BIOLOGICAL:** AC133
- **BIOLOGICAL:** MNC
- **BIOLOGICAL:** CONTROL

## Key facts

- **NCT ID:** NCT01187654
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-09
- **Final completion:** 2012-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187654, "Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01187654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*